A Commentary: Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?

被引:1
|
作者
Flemming, Heather [1 ]
Hoffman, Robert [2 ]
机构
[1] Dalhousie Univ, Halifax Regional Municip, NS, Canada
[2] NYU, New York, NY USA
关键词
D O I
10.1016/j.annemergmed.2017.09.033
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:268 / 268
页数:1
相关论文
共 50 条
  • [1] Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?
    Brown, Michael
    Carlson, Jestin
    Jones, Alan
    [J]. ANNALS OF EMERGENCY MEDICINE, 2017, 69 (06) : 740 - 742
  • [2] α2-adrenergic agonists in opioid withdrawal
    Gowing, LR
    Farrell, M
    Ali, RL
    White, JM
    [J]. ADDICTION, 2002, 97 (01) : 49 - 58
  • [3] Alpha2-adrenergic agonists for the management of opioid withdrawal
    Gowing, Linda
    Farrell, Michael F.
    Ali, Robert
    White, Jason M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [4] Alpha2-adrenergic agonists for the management of opioid withdrawal
    Gowing, Linda
    Farrell, Michael
    Ali, Robert
    White, Jason M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
  • [5] Alpha2-adrenergic agonists for the management of opioid withdrawal
    Gowing, Linda
    Farrell, Michael
    Ali, Robert
    White, Jason M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [6] β2-adrenergic agonists and doping: Where do we stand?
    Lourenco, Olga
    Cardoso, Ana
    Monico, Beatriz
    Gama, Jorge M. R.
    Neiva, Henrique P.
    Marinho, Daniel A.
    [J]. ALLERGY, 2021, 76 (07) : 2320 - 2321
  • [7] β2-adrenergic agonists do not improve physical performance in healthy individuals
    Cardoso, Ana
    Monico, Beatriz
    Gama, Jorge M. R.
    Neiva, Henrique P.
    Marinho, Daniel A.
    Lourenco, Olga
    [J]. ALLERGY, 2021, 76 (07) : 2201 - 2203
  • [8] Clinical uses of α2-adrenergic agonists
    Kamibayashi, T
    Maze, M
    [J]. ANESTHESIOLOGY, 2000, 93 (05) : 1345 - 1349
  • [9] Vasocontractile effects of α2-adrenergic agonists associated with intracellular calcium release
    López, O
    Gil-Gastelum, O
    Medina, R
    Castillo, EF
    Castillo, C
    [J]. PROCEEDINGS OF THE FORTY-FIFTH ANNUAL MEETING OF THE WESTERN PHARMACOLOGY SOCIETY, 2002, 45 : 90 - 91
  • [10] Neuroprotective effects of α2-adrenergic receptor agonists
    Weber, Bernd
    Steinfath, Markus
    Scholz, Jens
    Bein, Berthold
    [J]. DRUG NEWS & PERSPECTIVES, 2007, 20 (03) : 149 - 154